CompletedNot Applicable

Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)

France51 participantsStarted 2017-09-04

Plain-language summary

This study investigates the efficacy of probiotic VSL#3 as an add on standard care on the activity of the disease in patients with Juvenile Idiopathic Arthritis.

Who can participate

Age range1 Year – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥1year and \<7years * Patients with oligoarthritis and polyarthritis with rheumafactor negative and antinuclear antibodies (ANA) positive JIA with onset before the age of 6 years Exclusion Criteria: * Change of JIA forme

What they're measuring

To evaluate the impact of a regular intake of probiotic VSL#3 in addition to standard treatment in patients with JIA on the clinical activity

Timeframe: 3 months

Trial details

NCT IDNCT03092427

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-04

View on ClinicalTrials.gov More Juvenile Idiopathic Arthritis trials